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Abstract
Kawasaki disease is an acute febrile disease of unknown etiology, characterized by systemic vascular inflammation
involving the small and medium sized arteries, with a predilection for the coronary arteries. It represents the
leading cause of acquired heart diseases in children in developed countries. Diagnosis, difficult because of the
clinical characteristics of the disease with typical signs and symptoms appearing sequentially and not
simultaneously, may be even more complicated in case of unusual presentation, leading to delay in recognition,
particularly in infant in whom a higher incidence of coronary arteries aneurysms has been reported. A high index
of suspicion of Kawasaki disease must be maintained in case of prolonged fever in these patients. Timely
appropriate treatment is essential to avoid severe sequels. We report the case of a 2 months old male infant with
persistent febrile episode, transferred to us from another institution, who presented on echocardiography giant
aneurysms on both coronary arteries.
Introduction
Kawasaki disease is an acute febrile disease of unknown
etiology, characterized by systemic vascular inflamma-
tion involving the small and medium sized arteries, with
a predilection for the coronary arteries, first describe by
Tomisaku Kawasaki in Japan in 1967 [1,2]. The disease,
counts for the leading cause of acquired cardiac disease
in the developed countries, with an annual estimated
incidence of 112 cases/100000 children in Japan and 2.9
- 6.9 cases/100000 children in Europe. About 80% of
the children with Kawasaki disease are younger than 5
years of age with the peak of incidence between 6 and
11 months. The disease is rare in neonatal and infant
period (only 1.6% of patients are under 90 days of age)
[3] and extremely rare in adolescents and adults. Hospi-
talization rate of children under 5 years of age in the
US was about 20.8/100000 in 2006 and remained con-
stant from 1997 to 2007 [4-6]. The diagnosis relies only
on fever associated with transient typical signs and
symptoms appearing sequentially, usually not simulta-
neously present at the time of physical examination,
therefore requiring an extremely precise case history.
Difficulty in the diagnosis is increased by unusual and
incomplete presentation, that may lead to delay in
recognition and treatment and therefore severe sequels
particularly in infant who are reported to have a higher
incidence of coronary aneurysms [7-13]. Prompt and
appropriate treatment with intravenous immunoglobulin
(IVIG) associated with acetyl salicylic acid significantly
reduces the risk of cardiac complications [14-18].
Among the untreated patients 25% of patients develop
cardiac complications, declining to 5% in the patients
who underwent the appropriate treatment 16. We
report on a 2 month old male infant with persistent
fever, transferred to us from another institution, who
presented giant aneurysms of both coronary arteries on
echocardiography.
Case Report
A 2 month old male infant was referred to our Hospital
by another institution where he was admitted one week
earlier for a two day history of fever, loss of appetite
and rash. At that time laboratory studies showed an ele-
vation of white blood cells (WBC 19.290/mm3). Chest
x-ray and abdominal, cerebral and cardiac ultrasound
were performed and urine, blood and cerebrospinal fluid
(CSF) samples for culture were obtained. All these tests
were negative. Therefore a systemic antibiotic therapy
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two days switched to ceftriaxone and teicoplanin. More-
over a low dose of IGIV was given. On arrival in our
Institution the patient was still febrile. Physical examina-
tion showed skin pallor, conjunctivitis and flushed lips,
tachycardia, with normal heart sounds, no murmur,
tachypnea; an echocardiography was performed, which
resulted normal, as well as Chest X-ray, abdominal and
cerebral ultrasound. Lumbar puncture was also per-
formed and blood samples were obtained for complete
blood cell count and culture. Laboratory studies showed
increased WBC (28.830/mm3), platelets (575000/mm3)
and Reactive Protein C (RCP 308 mg/L) and low hemo-
globin (7.3 g/dL). The infant underwent red blood cell
transfusion and antibiotic therapy with ampicillin and
gentamicin was continued. On the second day ankle
edema appeared while fever disappeared; blood exami-
nation revealed a significant reduction of RCP (72.4 mg/
L) and WBC (21.910/mm3) with platelets persistently
increasing (909000/mm3). The child remained well and
apyretic for 7 days, then fever recurred, associated with
irritability, tachycardia, skin rash on physical examina-
tion, and RCP at 239 mg/L (normal range 0 - 5 in our
laboratory) and further increase of platelets (1170000/
mm3) on laboratory investigations. The scheduled echo-
cardiography was immediately performed and showed
mitral valve insufficiency, pericardial effusion and severe
anomalies on both coronary arteries: 3 aneurysms from
5 to 6 mm in diameter on the right coronary artery; left
main coronary, normal proximally, was progressively
dilated distally, as well as the circumflex artery, and
there was a tubular aneurysm of 5 mm on the left ante-
rior descending artery. Infusion of IVIG (2 gr/Kg in a
single dose in twelve hours) and administration of acetyl
salicylic acid (100 mg/Kg in 4 doses) was immediately
started along with low molecular weight heparin
(LMWH). Rapid improvement in clinical status, a signif-
icant decrease in RCP and platelet values (RCP 139 mg/
L, platelets 882000/mmc) with complete normalization
20 days after IVIG infusion was observed. LMWH was
then switched to Warfarin. The child was discharged 40
days after admission with acetyl salicylic acid and war-
farin therapy, monitored by CoaguCheck System to
maintain INR between 2.0 and 2.5. During follow up
coronary aneurysms gradually improved. The last car-
diac ultrasound showed a 5 mm left coronary artery
aneurysm but right coronary artery was not observable.
Mitral valve insufficiency and pericardial effusion were
no longer present. A Cardiac catheterization was per-
formed to study the coronary arteries which confirmed
the presence of a 5 mm left coronary artery aneurysm
with thrombus, and showed the interruption of the right
coronary artery 18 mm from its origin (Figure 1).
Currently the child receives acetyl salicylic acid 5 mg/Kg
and warfarin 0.28 mg/Kg.
Discussion
Diagnosis of Kawasaki’s disease is a demanding chal-
lenge because it relies essentially on clinical criteria,
with typical signs and symptoms similar to those present
in different common children’s diseases, appearing
sequentially and fleeting. In our case an a posteriori
audit of the first week report showed that the patient
presented a fleeting episode of palm erythema along
with edema of the hands and feet. Erroneous treatment
due to mistake in the interpretation of signs and symp-
toms may alter clinical status and feature without modi-
fying the course of the disease leading to a delay in the
diagnosis and the timing of proper therapy. In our case
the patient was given a low dose of IVIG which can-
celled the fever and improved the clinical status for a
week which only transiently slowed down the inflamma-
tory process, leading to significant delay in the diagnosis
and severe sequels. The key is a precise and well-done
case history, and a close physical examination. Labora-
tory studies, particularly inflammatory indexes such as
RCP may be helpful in the presence of clinical signs.
Abnormal platelet count along with clinical signs and
RCP value is revealing but is a late index which usually
Figure 1 LCA: main left coronary artery dilated with normal
distribution and perfusion beyond the aneurysm. Aneurysm:
aneurysm of 5 mm in diameter at the bifurcation of the left
coronary artery. RCA: thin right coronary artery, interrupted at 18
mm from its origin.
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ment should be given between the 6th and the 8th day.
In our case abnormal platelet count along with a revi-
sion of the history and the other laboratory data should
have raised the suspect of Kawasaki disease even in the
presence of a completely negative echocardiography
with the rapid disappearance of the fever. Unusual pre-
sentation is an important risk factor for delay in the
diagnosis and severe cardiac sequels. Infants younger
than one year of age are at the highest risk for coronary
aneurysms and frequently show atypical forms of the
disease [19,20]. In this category of patients, in case of
fever lasting more than three consecutive days, Kawasaki
disease should be considered in differential diagnosis.
Delayed diagnosis, along with incomplete clinical man-
ifestation, has been suggested to be the major contribu-
tor to the development of coronary artery aneurysms.
Timely appropriate treatment is essential for the avoid-
ance of serious sequels in Kawasaki disease, particularly
coronary aneurysms, especially in infants younger than
one year of age in whom a high index of suspicion of
Kawasaki disease must be maintained in case of pro-
longed fever. The key relies on a precise, detailed and
complete case history and careful clinical evaluation and
monitoring.
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